Outcomes of Descemet’s membrane endothelial keratoplasty in patients with previous glaucoma

Session Details

Session Title: Surgical Cornea: Keratoplasty & Corneal Grafts

Session Date/Time: Sunday 23/09/2018 | 14:00-16:00

Paper Time: 14:06

Venue: Room A3, Podium 3

First Author: : N.Cesario Pereira BRAZIL

Co Author(s): :    A. dos Santos Forseto   H. Delloiagono   M. Wong   J. Pereira Gomes           

Abstract Details

Purpose:

To describe the clinical outcomes of Descemet's membrane endothelial keratoplasty (DMEK) in glaucoma patients.

Setting:

Sorocaba Eye Bank / Sorocaba Ophthalmology Hospital.

Methods:

Retrospective study, including 55 eyes of 48 patients with glaucoma undergoing DMEK by a single surgeon (NCP) from July 2013 to July 2017 at Sorocaba Eye Bank /Sorocaba Ophthalmology Hospital. Best-corrected visual acuity, biomicroscopy, previous eyes diseases and complications were evaluated.

Results:

There were 27 patients with glaucoma controlled previously with surgery (trabeculectomy and/or tube) in the surgical treatment group and 28 patients controlled previously with medical treatment (eye drops) without glaucoma surgery in the medical treatment group. One patient from the medical treatment group had a primary graft failure due to a toxic anterior segment syndrome. Two patients (8.7%) from the surgical treatment group required rebubbling. Only one patient (3.6%) from the medical treatment group required rebubbling. One patient in the medical treatment group required glaucoma surgery after DMEK to control intraocular pressure.

Conclusions:

DMEK in patients with glaucoma can result in good outcomes, with more rebubbling in patients with previous glaucoma surgery.

Financial Disclosure:

-